Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers

INTRODUCTION: Human epidermal growth factor receptor-2 (HER2) gene amplification (HER2+) drives tumor cell growth and survival in ~25 % of breast cancers. HER2 signaling activates the type I phosphoinositide 3-kinase (PI3K), upon which these tumors rely. Consequently, inhibitors of HER2 and type I P...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, Christian D., Arteaga, Carlos L., Cook, Rebecca S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670529/
https://www.ncbi.nlm.nih.gov/pubmed/26637440
http://dx.doi.org/10.1186/s13058-015-0656-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670529/
https://www.ncbi.nlm.nih.gov/pubmed/26637440
http://dx.doi.org/10.1186/s13058-015-0656-2

Ejemplares similares